BioArctic

317.00 SEK

+1.54 %

Less than 1K followers

BIOA B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

+1.54 %
-1.37 %
-13.01 %
+1.99 %
+13.13 %
+80.83 %
+3.26 %
+309.03 %
+993.10 %

BioArctic is a biopharmaceutical company focused on developing new treatments that address the causes of neurodegenerative diseases. Examples of diseases include Alzheimer's and Parkinson's. A large part of the research is carried out in collaboration with researchers at universities and hospitals. BioArctic was founded in 2003 and is headquartered in Stockholm.

Read more
Market cap
28.12B SEK
Turnover
91.28M SEK
Revenue
2B
EBIT %
62.97 %
P/E
27.45
Dividend yield-%
0.63 %
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
20.5
2026

Interim report Q1'26

28.5
2026

General meeting '26

29.5
2026

Annual dividend

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.